skingen uk ltd

1.5

skingen uk ltd Company Information

Share SKINGEN UK LTD
Live (In Liquidation)
EstablishedSmallDeclining

Company Number

07428994

Registered Address

battle house oxford court, manchester, M2 3WQ

Industry

Wholesale of pharmaceutical goods

 

Telephone

01260271666

Next Accounts Due

246 days late

Group Structure

View All

Directors

Aileen Cameron13 Years

David Bryant9 Years

View All

Shareholders

skingen international inc 100%

skingen uk ltd Estimated Valuation

£1.6m

Pomanda estimates the enterprise value of SKINGEN UK LTD at £1.6m based on a Turnover of £2.4m and 0.65x industry multiple (adjusted for size and gross margin).

skingen uk ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of SKINGEN UK LTD at £0 based on an EBITDA of £-138.4k and a 5.12x industry multiple (adjusted for size and gross margin).

skingen uk ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of SKINGEN UK LTD at £0 based on Net Assets of £-857.1k and 2.11x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Skingen Uk Ltd AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Skingen Uk Ltd Overview

Skingen Uk Ltd is a live company located in manchester, M2 3WQ with a Companies House number of 07428994. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in November 2010, it's largest shareholder is skingen international inc with a 100% stake. Skingen Uk Ltd is a established, small sized company, Pomanda has estimated its turnover at £2.4m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Skingen Uk Ltd Health Check

Pomanda's financial health check has awarded Skingen Uk Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 8 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating1.5out of 5
positive_score

2 Strong

positive_score

2 Regular

positive_score

8 Weak

size

Size

annual sales of £2.4m, make it smaller than the average company (£26.3m)

£2.4m - Skingen Uk Ltd

£26.3m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -10%, show it is growing at a slower rate (4.6%)

-10% - Skingen Uk Ltd

4.6% - Industry AVG

production

Production

with a gross margin of 26.6%, this company has a comparable cost of product (26.6%)

26.6% - Skingen Uk Ltd

26.6% - Industry AVG

profitability

Profitability

an operating margin of -5.7% make it less profitable than the average company (4.7%)

-5.7% - Skingen Uk Ltd

4.7% - Industry AVG

employees

Employees

with 5 employees, this is below the industry average (42)

5 - Skingen Uk Ltd

42 - Industry AVG

paystructure

Pay Structure

on an average salary of £68.2k, the company has an equivalent pay structure (£68.2k)

£68.2k - Skingen Uk Ltd

£68.2k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £485.6k, this is less efficient (£623.1k)

£485.6k - Skingen Uk Ltd

£623.1k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 77 days, this is later than average (58 days)

77 days - Skingen Uk Ltd

58 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 54 days, this is slower than average (26 days)

54 days - Skingen Uk Ltd

26 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 9 days, this is less than average (70 days)

9 days - Skingen Uk Ltd

70 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (14 weeks)

0 weeks - Skingen Uk Ltd

14 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 247.6%, this is a higher level of debt than the average (55%)

247.6% - Skingen Uk Ltd

55% - Industry AVG

skingen uk ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for skingen uk ltd. Get real-time insights into skingen uk ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Skingen Uk Ltd Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for skingen uk ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.

skingen uk ltd Ownership

SKINGEN UK LTD group structure

Skingen Uk Ltd has no subsidiary companies.

Ultimate parent company

SKINGEN INTERNATIONAL INC

#0090919

1 parent

SKINGEN UK LTD

07428994

SKINGEN UK LTD Shareholders

skingen international inc 100%

skingen uk ltd directors

Skingen Uk Ltd currently has 3 directors. The longest serving directors include Ms Aileen Cameron (Nov 2010) and Mr David Bryant (Aug 2014).

officercountryagestartendrole
Ms Aileen Cameron60 years Nov 2010- Director
Mr David Bryant55 years Aug 2014- Director
Ms Fateme Gheshlagh47 years Jul 2017- Director

SKINGEN UK LTD financials

EXPORTms excel logo

Skingen Uk Ltd's latest turnover from December 2021 is estimated at £2.4 million and the company has net assets of -£857.1 thousand. According to their latest financial statements, Skingen Uk Ltd has 5 employees and maintains cash reserves of £1.8 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Nov 2014Nov 2013Nov 2012Nov 2011
Turnover2,428,1101,866,5801,645,8713,309,7671,433,135277,099389,3171,000,049628,831307,93259,498
Other Income Or Grants00000000000
Cost Of Sales1,783,4821,363,5691,210,8202,433,2511,045,933198,591280,118737,475465,274235,10028,508
Gross Profit644,628503,011435,051876,516387,20278,507109,199262,573163,55772,83330,990
Admin Expenses783,244525,988711,801890,912568,277-40,192156,920374,856208,828214,040193,042
Operating Profit-138,616-22,977-276,750-14,396-181,075118,699-47,721-112,283-45,271-141,207-162,052
Interest Payable3,2671,66400615900000
Interest Receivable2320212061561112910
Pre-Tax Profit-141,881-24,638-276,730-14,375-181,116118,646-47,706-112,222-45,159-141,116-162,052
Tax00000-23,72900000
Profit After Tax-141,881-24,638-276,730-14,375-181,11694,917-47,706-112,222-45,159-141,116-162,052
Dividends Paid00000000000
Retained Profit-141,881-24,638-276,730-14,375-181,11694,917-47,706-112,222-45,159-141,116-162,052
Employee Costs341,164333,120318,247379,812179,24857,86352,91986,90182,41242,09340,245
Number Of Employees55563112211
EBITDA*-138,438-22,740-276,434-14,396-179,421119,414-47,321-111,883-44,871-141,207-162,052

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Nov 2014Nov 2013Nov 2012Nov 2011
Tangible Assets5347129491,26501,6543687681,16800
Intangible Assets00000000000
Investments & Other000001,6281,6280000
Debtors (Due After 1 year)00000000000
Total Fixed Assets5347129491,26503,2821,9967681,16800
Stock & work in progress46,13912,16531,893044,26149,77356,96970,58356,74933,28964,080
Trade Debtors512,365480,227367,653179,088108,60825,02235,342100,362101,56529,3248,201
Group Debtors00000126,3003,0890000
Misc Debtors19,80100007,2449,6910008,215
Cash1,75105,33105,6942,3372,8553,28221,23523,70412,750
misc current assets00000000000
total current assets580,056492,392404,877179,088158,563210,676107,946174,227179,54986,31793,246
total assets580,590493,104405,826180,353158,563213,958109,942174,995180,71786,31793,246
Bank overdraft04,5570001,88200000
Bank loan00000000000
Trade Creditors 264,19170,58489,161772,981433,07557,23977,436266,045103,34771,78810,139
Group/Directors Accounts789,263889,632918,50000105,77660,0000000
other short term finances00000000000
hp & lease commitments00000000000
other current liabilities334,214193,52888,72400205,784115,24100050,159
total current liabilities1,387,6681,158,3011,096,385772,981433,075370,681252,677266,045103,34771,78860,298
loans50,00050,000000000000
hp & lease commitments00000000000
Accruals and Deferred Income00016,2010000000
other liabilities0000125,01661,615170,520174,499230,697122,6970
provisions00000000000
total long term liabilities50,00050,000016,201125,01661,615170,520174,499230,697122,6970
total liabilities1,437,6681,208,3011,096,385789,182558,091432,296423,197440,544334,044194,48560,298
net assets-857,078-715,197-690,559-608,829-399,528-218,338-313,255-265,549-153,327-108,16832,948
total shareholders funds-857,078-715,197-690,559-608,829-399,528-218,338-313,255-265,549-153,327-108,16832,948
Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Nov 2014Nov 2013Nov 2012Nov 2011
Operating Activities
Operating Profit-138,616-22,977-276,750-14,396-181,075118,699-47,721-112,283-45,271-141,207-162,052
Depreciation17823731601,65471540040040000
Amortisation00000000000
Tax00000-23,72900000
Stock33,974-19,72831,893-44,261-5,512-7,196-13,61413,83423,460-30,79164,080
Debtors51,939112,574188,56570,480-49,958110,444-52,240-1,20372,24112,90816,416
Creditors193,607-18,577-683,820339,906375,836-20,197-188,609162,69831,55961,64910,139
Accruals and Deferred Income140,686104,80472,52316,201-205,78490,543115,24100-50,15950,159
Deferred Taxes & Provisions00000000000
Cash flow from operations109,942-29,359-1,108,189315,49246,10162,783-54,83538,184-109,013-111,834-182,250
Investing Activities
capital expenditure000-1,2650-2,00100-1,56800
Change in Investments0000-1,62801,6280000
cash flow from investments000-1,2651,628-2,001-1,6280-1,56800
Financing Activities
Bank loans00000000000
Group/Directors Accounts-100,369-28,868918,5000-105,77645,77660,0000000
Other Short Term Loans 00000000000
Long term loans050,000000000000
Hire Purchase and Lease Commitments00000000000
other long term liabilities000-125,01663,401-108,905-3,979-56,198108,000122,6970
share issue00195,000-194,926-7400000195,000
interest-3,265-1,6612021-41-531561112910
cash flow from financing-103,63419,4711,113,520-319,921-42,490-63,18256,036-56,137108,112122,788195,000
cash and cash equivalents
cash1,751-5,3315,331-5,6943,357-518-427-17,953-2,46910,95412,750
overdraft-4,5574,55700-1,8821,88200000
change in cash6,308-9,8885,331-5,6945,239-2,400-427-17,953-2,46910,95412,750

P&L

December 2021

turnover

2.4m

+30%

operating profit

-138.6k

0%

gross margin

26.6%

-1.48%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2021

net assets

-857.1k

+0.2%

total assets

580.6k

+0.18%

cash

1.8k

0%

net assets

Total assets minus all liabilities

skingen uk ltd company details

company number

07428994

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

November 2010

age

14

accounts

Total Exemption Full

ultimate parent company

SKINGEN INTERNATIONAL INC

previous names

silderm limited (November 2017)

incorporated

UK

address

battle house oxford court, manchester, M2 3WQ

last accounts submitted

December 2021

skingen uk ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to skingen uk ltd. Currently there are 2 open charges and 0 have been satisfied in the past.

charges

skingen uk ltd Companies House Filings - See Documents

datedescriptionview/download